Sector News

Medtronic launches Infinity upper spine surgery immobilization system

October 8, 2018
Life sciences

Medtronic launched a surgical system in the U.S. designed to immobilize the thoracic and cervical spine during complex procedures and assist surgeons with navigation.

The Infinity Occipitocervical-Upper Thoracic System features a multi-axial screw that can move 60 degrees in any direction, as well as 3.0mm and 5.5mm diameter screws for a range of patient demographics and clinical applications.

The system also includes a spectrum of implant materials and sizes, and can be paired with the company’s O-arm imaging and StealthStation navigation systems.

Medtronic announced the launch during the annual meeting of the North American Spine Society in Los Angeles, and plans to make the system available globally over the next year. The Infinity OCT System is indicated for conditions including degenerative disc disease, instability or deformity, tumors, and traumatic spinal fractures or traumatic dislocations.

Last month, Medtronic announced it would acquire the remainder of Mazor Robotics, a developer of digitally-assisted spine surgery guidance systems, and plans to merge the company with its own implants, navigation and imaging products.

The $1.6 billion deal is the culmination of a phased investment agreement between the two companies that began in 2016, and Medtronic plans to maintain Mazor’s site and team in Caesarea, Israel.

“We believe robotic-assisted procedures are the future of spine surgery, enhancing surgeons’ abilities to perform complex procedures with greater precision, consistency and control,” Geoff Martha, president of Medtronic’s Restorative Therapies Group, said at the time.

By: Conor Hale

Source: Fierce Biotech

comments closed

Related News

October 1, 2023

Clinical data from Boston Scientific and rivals could reshape pulmonary embolism market: analysts

Life sciences

After attending the annual Pulmonary Embolism Symposium last week in Austin, Texas, the analysts predicted clinical guidelines could shift toward catheter-based therapy once data from ongoing randomized trials is available.

October 1, 2023

AstraZeneca and SAS link up on AI and analytics

Life sciences

SAS – the AI and analytics company – has been selected by AstraZeneca to help boost efficiency and drive automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.

October 1, 2023

Will Big Pharma engage in Medicare price negotiations? Merck, AZ and BMS say they will

Life sciences

After the Centers for Medicare & Medicaid Services (CMS) revealed the list of drugs set to face the first round of price negotiations under the Inflation Reduction Act (IRA), the drugmakers responsible for marketing them are confronting a series of deadlines.

How can we help you?

We're easy to reach